Related Experiment Video
Updated: May 17, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
Ultraviolet A1 phototherapy for mycosis fungoides
K Olek-Hrab1, W Silny, A Dańczak-Pazdrowska
1Department of Dermatology, Poznan Medical University of Sciences, Poznan, Poland.
Background:
Mycosis fungoides (MF) is the most common form of primary cutaneous lymphoma, and is characterized by a malignant proliferation of CD4+ cells. Psoralen ultraviolet A (PUVA) irradiation is the most common treatment for cutaneous lesions. However, PUVA carries the risk of adverse reactions to psoralens and long-term risk of skin cancer. UVA1 may be a safer alternative.
Aim:
To assess the efficacy of UVA1 phototherapy in patients with early-stage MF (T1-T2).
Methods:
Four patients with early-stage MF were treated with 1630-2710 J/cm(2) UVA1 given in 29-40 fractions, and the effect was assessed by clinical examination and by high-resolution ultrasonography.
Results:
Complete clinical remission of MF was achieved in all cases.
Conclusions:
This preliminary report indicates that UVA1 phototherapy might be an efficient treatment for early-stage MF.
Insights
UVA1 phototherapy shows promise for treating early-stage mycosis fungoides (MF), a type of skin lymphoma. This study found complete remission in all patients treated with UVA1, suggesting it may be a safer alternative to PUVA.
Area of Science:
- Dermatology
- Oncology
- Photomedicine
Background:
- Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma.
- Current treatments like Psoralen ultraviolet A (PUVA) have risks.
- UVA1 phototherapy is explored as a potentially safer alternative.
Purpose of the Study:
- To evaluate the efficacy of UVA1 phototherapy for early-stage MF (T1-T2).
Main Methods:
- Four patients with early-stage MF received UVA1 treatment.
- Dosage ranged from 1630-2710 J/cm(2) over 29-40 fractions.
- Assessment included clinical examination and high-resolution ultrasonography.
Main Results:
- Complete clinical remission of MF was observed in all treated patients.
Conclusions:
- UVA1 phototherapy appears to be an effective treatment for early-stage mycosis fungoides.
- This preliminary study suggests UVA1 as a viable therapeutic option.
Related Concept Videos
Acne Infection
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

